Duopharma Biotech Berhad (KLSE:DPHARMA)

Malaysia flag Malaysia · Delayed Price · Currency is MYR
1.270
-0.020 (-1.55%)
At close: Apr 27, 2026
7.63%
Market Cap 1.24B
Revenue (ttm) 931.69M
Net Income (ttm) 87.46M
Shares Out 961.94M
EPS (ttm) 0.09
PE Ratio 14.19
Forward PE 12.26
Dividend 0.05 (3.58%)
Ex-Dividend Date Mar 12, 2026
Volume 535,900
Average Volume 355,325
Open 1.300
Previous Close 1.290
Day's Range 1.260 - 1.300
52-Week Range 1.160 - 1.570
Beta 0.47
RSI 40.98
Earnings Date May 15, 2026

About Duopharma Biotech Berhad

Duopharma Biotech Berhad, an investment holding company, researches, develops, manufactures, distributes, and imports pharmaceutical products and medicines in Malaysia and internationally. The company offers consumer healthcare products, such as vitamins, minerals, and supplements, analgesics, eyecare, antacids, and skin care products; and generic drugs for various therapeutic classes, such as cardiovascular, dermatology, hormones, respiratory, sensory and nervous system, musculo-skeletal system, anti-infectives, and others. It also provides sp... [Read more]

Industry Pharmaceutical Preparations
Founded 1978
Employees 1,957
Stock Exchange Bursa Malaysia
Ticker Symbol DPHARMA
Full Company Profile

Financial Performance

In 2025, Duopharma Biotech Berhad's revenue was 931.69 million, an increase of 14.50% compared to the previous year's 813.70 million. Earnings were 87.46 million, an increase of 39.62%.

Financial Statements

News

There is no news available yet.